1. Home /
  2. Drug Approvals

Drug Approvals

2 Small Biotechs That Have Attracted My Attention and My Cash

BioXcel Therapeutics and Avadel Pharmaceuticals are new additions to my personal portfolio based on their promising drug prospects.

Just Another Wild Day on the Small-Cap Biotech Rollercoaster

Use long-dated calls to take some of risk out of this inherently high-beta space.

Waves of Buying, Above-Average Indices, Vaccine Mania: Market Recon

Plus, reading tea leaves in the recent action in Apple and Salesforce.com.

Jim Cramer: Abbott Labs and the Rally in Travel

ABT will end the issues of flying and cruising. Of course it's another story when you get there. But boarding will be solved.

A Healthy Dose of Vaccine and Pharmaceutical Plays

6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.

Apple Still King, Dow Shell Game, More Market Faith, Renewed China Talks?

Monday's market action was in no way similar to that recent disparity between the 'haves' and 'have nots.'

Here's How I'm Trading XBiotech

Do these shares get back to the 2020 highs that were reached back in January?

Will Mydecine's Move Make the Market for Pharmaceutical Psilocybin Mushroom?

Psychedelic companies hoping to capitalize on a surging interest in psilocybin treatments have been limited to one source for research grade psilocybin. Until now.

BioMarin's FDA Setback Opens New Opportunities for the Stock

A simple covered call strategy seems appropriate here.

Here's How Patient Investors Could Buy Vertex Pharmaceuticals

The short-term charts of VRTX suggest that this stock can see further sideways to lower price action in the weeks ahead.